Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2017
Pharma News, 2017
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
It was only August when Merck and GlaxoSmithKline had to deal with a global shortage for their hepatitis B vaccines, and now unexpected demand in the U.
With only 2 warnings in 2017, pharma's ad police hits historic low
As the end of the year nears, the pharma industry can usually look back at FDA enforcement letters for insight into the agency's thinking and guidance on marketing communications.
EMA Recommends Ten Drugs for Approval
At the November 2017 meeting of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), 10 new medicines were recommended for approval.
Dr. Reddy’s introduces generic Clolar injection
PRINCETON, N.
Spain's Almirall warns of delay in approval for psoriasis drug
Spanish pharma company Almirall said on Tuesday it expects the launch of psoriasis treatment drug, Tildrakizumab, in Europe to get delayed by at least six months due to regulatory hurdles.
Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
STAMFORD, Conn.
Cost of diabetes epidemic reaches $850 billion a year
(Reuters) - The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said on Tuesday.
Kadmon Initiates Phase 2 Placebo-Controlled Clinical Trial of Tesevatinib in Autosomal Dominant Polycystic Kidney Disease
NEW YORK, NY, USA I November 13, 2017 I Kadmon Holdings, Inc.
California Institute of Biomedical Research and Excelra Knowledge Solutions Enter into Database Licensing Agreement
HYDERABAD, India--(BUSINESS WIRE)--Excelra Knowledge Solutions Pvt.
Nanotech, gene editing used to edit cholesterol gene: U.S. study
CHICAGO (Reuters) - U.
Bill Gates makes $100 million personal investment to fight Alzheimer's
LONDON, Nov 13 (Reuters) - Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and governm...
Dr. Reddy's launches generic Vidaza in Canada
PRINCETON, N.
7
8
9
10
11
12
13
14
15
